References of "Amory, Hélène"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailApproche diagnostique des myopathies chez le cheval
Van Galen, Gaby ULg; Serteyn, Didier ULg; Amory, Hélène ULg et al

in Le nouveau Praticien vétérinaire équine (2008), 15

Detailed reference viewed: 75 (22 ULg)
Full Text
Peer Reviewed
See detailVegetative endocarditis in the horse: retrospective study
Porter, Sarah ULg; Saegerman, Claude ULg; Van Galen, Gaby ULg et al

in Journal of Veterinary Internal Medicine (2008), 22(6), 1411-1416

Detailed reference viewed: 19 (6 ULg)
See detailElaboration of a PK/PD model of tiludronate in horses: a preliminary study
Delguste, Catherine ULg; Doucet, M; Lepage, O et al

Report (2008)

Detailed reference viewed: 4 (0 ULg)
Full Text
See detailPhysiopathology and therapy of chronic heart failure in the equine species
Amory, Hélène ULg; Deleuze, Stefan ULg; Sandersen, Charlotte ULg

in Proceedings of the Second Resident Meeting of the European College of Equine Internal medicine (ECEIM) (2008)

Detailed reference viewed: 9 (1 ULg)
Full Text
See detailCushing et syndrome métabolique équin
Amory, Hélène ULg

in Proceedings of the 25th Annual Congress of the Belgian Equine Practitioners Society (BEPS) (2008)

Detailed reference viewed: 27 (5 ULg)
Full Text
Peer Reviewed
See detailMorphological echocardiographic measurements: reference values as a function of body size in equids
Al Haidar, A; Sandersen, Charlotte ULg; Van Erck, Emmanuelle et al

Poster (2008)

Detailed reference viewed: 9 (0 ULg)
Full Text
See detailDifferential diagnosis of equine systolic murmurs
Amory, Hélène ULg

in In the Proceedings of the Voorjaardagen Congress (2008)

Detailed reference viewed: 5 (0 ULg)
Full Text
See detailBiomarkers of heart disease
Amory, Hélène ULg; Deleuze, Stefan ULg; Sandersen, Charlotte ULg

in Proceedings of the Second Resident Meeting of the European College of Equine Internal medicine (ECEIM) (2008)

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailDiagnostiquer et traiter les endocardites chez le cheval.
Amory, Hélène ULg

in Nouveau Praticien Vétérinaire Equine (2008), 5

Detailed reference viewed: 38 (0 ULg)
Full Text
Peer Reviewed
See detailIntérêt de la troponine sérique en tant que marqueur d’une atteinte du myocarde en médecine vétérinaire
Sandersen, Charlotte ULg; Remy, Benoit; Olejnik, Dorine ULg et al

in Annales de Médecine Vétérinaire (2008)

Detailed reference viewed: 19 (3 ULg)
See detailElaboration of a PK/PD model of tiludronate in horses: a preliminary study
Delguste, Catherine ULg; Doucet, Michèle; Lepage, Olivier M et al

Report (2008)

Detailed reference viewed: 13 (7 ULg)
Peer Reviewed
See detailEffect of acepromazine on whole blood viscosity in horses
Sandersen, Charlotte ULg; Serteyn, Didier ULg; Dringenberg, Bernhard et al

in Proceedings (2008)

Detailed reference viewed: 16 (4 ULg)
Full Text
Peer Reviewed
See detailAtypical myopathy: new insights into the pathophysiology, prevention and management of the condition
Van Galen, Gaby ULg; Serteyn, Didier ULg; Amory, Hélène ULg et al

in Equine Veterinary Education (2008), 20(5), 234-238

Detailed reference viewed: 39 (7 ULg)
Full Text
Peer Reviewed
See detailTetanus in the equine species: a retrospective study of 31 cases.
Van Galen, Gaby ULg; Delguste, Catherine ULg; Sandersen, Charlotte ULg et al

in Tijdschrift voor Diergeneeskunde (2008), 133(12), 512-7

BACKGROUND: Few studies exist about factors affecting the outcome of horses with tetanus. ANIMALS: 31 equids (30 horses and 1 donkey) with a clinical diagnosis of tetanus admitted to the Equine Clinic of ... [more ▼]

BACKGROUND: Few studies exist about factors affecting the outcome of horses with tetanus. ANIMALS: 31 equids (30 horses and 1 donkey) with a clinical diagnosis of tetanus admitted to the Equine Clinic of the University of Liege between 1991 and 2006. The cases were divided into two groups according to the outcome (survivors and non-survivors). METHODS: The clinical data of survivors and non-survivors were compared using an ANOVA (continuous data) or a Fisher's test (discrete data). RESULTS: The survival rate was 32%. Most animals were 5 years or younger, and none had been appropriately vaccinated. The non-survivors were significantly younger than the survivors. The development of dyspnoea, recumbency, and the combination of dysphagia, dyspnoea, and recumbency was observed significantly more in the non-survivors than in the survivors. The timing of tetanus antitoxin administration (either immediately after the onset of suggestive signs or after a delay) was not different between the two groups. The time between the occurrence of a wound and the first signs ranged from 2 days to 2 months and was not significantly different between groups. All non-survivors died within 8 days of the first signs. CONCLUSIONS & CLINICAL IMPORTANCE: This study suggests that young animals are affected more often and more severely by tetanus than older animals. Dyspnoea, recumbency, and the combination of dysphagia, dyspnoea, and recumbency can be considered as indicators of a poor prognosis in equids suffering from tetanus. [less ▲]

Detailed reference viewed: 185 (17 ULg)
Full Text
Peer Reviewed
See detailPharmacological effects of tiludronate in horses after long-term immobilization
Delguste, Catherine ULg; Amory, Hélène ULg; Doucet, Michèle et al

in BONE (2007), 41(3), 414-421

Introduction: Tiludronate, a bisphosphonate, has recently been introduced in veterinary medicine to treat orthopedic conditions in the horse. This study was designed to evaluate its effects on biochemical ... [more ▼]

Introduction: Tiludronate, a bisphosphonate, has recently been introduced in veterinary medicine to treat orthopedic conditions in the horse. This study was designed to evaluate its effects on biochemical biomarkers of bone metabolism and on bone density and structure in an experimental model of disuse osteoporosis induced by cast application in horses. Methods: Two groups of eight horses were immobilized during 8 weeks. The first group (P-group) received a placebo, and the second group (T-group) received tiludronate 1 mg/kg by slow IV infusion. Both treatments were administered twice, 28 days apart. Immobilization consisted of stall rest with the left forelimb packed in a fiberglass cast. It was followed by a 4-week remobilization period and an 8-week standardized training protocol. One biomarker of bone resorption, the C-telopeptides of type 1 collagen cross-links (CTX-1) and one biomarker of bone formation, the bone isoenzyme of alkaline phosphatase (bone ALP), were assessed. Metacarpus III (MCIII) bone mineral density (BMD) and speed of sound (SOS) were evaluated respectively by dual energy X-ray absorptiometry (DEXA) and quantitative ultrasonography (QUS). Lameness was regularly assessed during the remobilization and training periods. Group- and time-related effects were tested by analysis of variance on repeated measurements. Results: A rapid, transient and significant decrease in CTX-1 concentration was seen after each treatment in the T-group only. No significant differences between groups were seen in the evolution of bone ALP activity. At the end of the experiment, the loss of MCIII BMD measured by DEXA in the immobilized limb was significantly less in the T-group than in the P-group. The MCIII SOS measured by QUS did not significantly vary within or between groups throughout the study. Discussion and conclusions: Tiludronate was found to significantly reduce bone resorption during immobilization, as well as to prevent long-term osteopenia in the immobilized limb. Disuse osteopenia did not affect the lateral superficial cortex of MCIII. (C) 2007 Elsevier Inc. All rights reserved. [less ▲]

Detailed reference viewed: 15 (1 ULg)
Peer Reviewed
See detailTetanus in the horse
Van Galen, Gaby ULg; Amory, Hélène ULg

Conference (2007, April 28)

Detailed reference viewed: 22 (1 ULg)
Full Text
Peer Reviewed
See detailPrévenir la myopathie atypique du cheval au pré par la gestion raisonnée des pâtures et des chevaux établie sur base de l'identification des facteurs de risques de la maladie
Votion, Dominique ULg; Delguste, Catherine ULg; Amory, Hélène ULg et al

in 33ème Journée de la Recherche Equine (2007, March 08)

La myopathie atypique (MA) des équidés est un syndrome de destruction musculaire massive et sévère affectant des chevaux séjournant en pâture. Cette myopathie, généralement fatale endéans les 72 heures ... [more ▼]

La myopathie atypique (MA) des équidés est un syndrome de destruction musculaire massive et sévère affectant des chevaux séjournant en pâture. Cette myopathie, généralement fatale endéans les 72 heures, est rencontrée en France de manière significative et récurrente depuis l’automne 2002. La Belgique a reconnu ses premiers cas de MA au cours de l’automne 2000. Grâce à la collecte systématique des données épidémiologiques et cliniques des cas belges confirmés par analyse histologique de muscles prélevés post mortem, il a été possible de définir les facteurs de risques contribuant à l’émergence de la maladie dans une prairie et/ ou au sein d’un élevage. A partir de ces facteurs de risques identifiés, des mesures de prévention de la MA sont proposées et discutées. [less ▲]

Detailed reference viewed: 101 (6 ULg)
Peer Reviewed
See detailThe composition of the inflammatory infiltrate in 3 cases of polyneuritis equi
Van Galen, Gaby ULg; Sandersen, Charlotte ULg; Delguste, Catherine ULg et al

in In Proccedings of the Second congress of the European College od Equine Internal Medicine (ECEIM) (2007, February 02)

Detailed reference viewed: 20 (7 ULg)